POST Online Media Lite Edition


Franz B. Humer to leave Roche

Staff writer |
Basel, Switzerland - March 7, 2013, Basel, Switzerland - Franz B. Humer, chairman of the board of directors of the Roche Group, announced that he will not stand for re-election to the board in 2014.

Article continues below

Mr. Humer started his career at ICME Zurich in 1971 and then joined Schering Plough Corporation where he worked, among other roles, as General Manager for Ecuador, United Kingdom, and Portugal. After that, he joined Glaxo Holdings where he was working as Area Manager for Southern Europe, Director of Marketing Development and Product Licensing, and Chief Operating Director.

After Glaxo, Mr. Humer joined F. Hoffmann-La Roche where he has been appointed as Member of the Board of Directors of the Roche Holding Ltd, Basel, and Head of the Pharmaceuticals Division. He was then named Chief Operating Officer of F. Hoffmann-La Roche Ltd, Chief Executive Officer Roche Holding Ltd, and Chairman of the Board of Directors of Roche Holding Ltd.

Mr. Humer also serves as Non-executive Chairman of Diageo, Member of the Board of Directors of Citigroup, Chairman of INSEAD, Member of the International Advisory Board of Allianz SE, Member of the Board of Directors of Jacobs Holding AG, and he is the Chairman of the Humer Stiftung.

Mr. Humer studied at the University of Innsbruck, he holds Doctor of Law title, and he also has an MBA degree from INSEAD. He received a honorary doctorates from the Faculty of Science, University of Basel and from London School of Pharmacy.


Glencore appoints David Wormsley as director
MoonLake Immunotherapeutics appoints chairman and director
Glencore appoints Kalidas Madhavpeddi as chairman
MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO
iOnctura appoints Joanna Horobin as chair

What to read next

Lufthansa chief is leaving the carrier
Zurich elects Christoph Franz to the board of directors
Roche NimbleGen announces Frank Pitzer as new CEO